Morphic Holding Inc (NASDAQ:MORF)

32.95
Delayed Data
As of Aug 12
 +3.83 / +13.15%
Today’s Change
19.23
Today|||52-Week Range
68.75
-30.46%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$1.3B

Company Description

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

Contact Information

Morphic Holding, Inc.
35 Gatehouse Drive A2
Waltham Massachusetts 02451
P:(781) 996-0955
Investor Relations:
--

Employees

Shareholders

Other institutional36.43%
Mutual fund holders33.74%
Individual stakeholders28.44%

Top Executives

Praveen P. TipirneniChief Executive Officer & Director
Bruce N. RogersPresident
Marc SchegerinChief Operating & Financial Officer
Brihad AbhyankarVice President-Clinical Development
Blaise LippaChief Scientific Officer